Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Infectious Disease

Managing the Infection: Treatment Options and Strategies

At a Glance

Toxocariasis is treated with a combination of anti-parasitic medications like albendazole to kill the larvae, and corticosteroids to control harmful inflammation as the parasites die. Eye infections may require specialized injections, laser therapy, or surgery to protect your child's vision.

Treating toxocariasis is a two-part process: first, killing the parasite, and second, controlling the body’s reaction to it. Because the larvae are hidden in tissues, treatment plans are often tailored to where the larvae are located and how much inflammation they have caused [1][2].

1. The Anti-Parasitic Medication: Albendazole

The primary medication used to treat toxocariasis is albendazole, an anthelmintic (anti-worm) drug [3].

  • How it Works: It prevents the larvae from moving or absorbing nutrients, eventually leading to their death [1].
  • Common Dosage: Your doctor will calculate the exact dose based on your child’s weight, age, and the specific type of infection [4]. The medication is typically taken for 5 to 15 days [5].
  • Side Effects and Safety: Albendazole is generally well-tolerated in children. Common side effects are usually mild and can include stomach upset, nausea, or dizziness. Doctors may monitor liver enzymes (via blood tests) if the medication is needed for a longer period [4][6].

2. The Critical Role of Corticosteroids

In toxocariasis, the larvae themselves are only half the problem. When the larvae die—either naturally or due to medication—they release substances that can trigger a severe “flare” of inflammation [2][7].

For this reason, corticosteroids (like prednisone or dexamethasone) are often used alongside albendazole, especially in Ocular Larva Migrans (OLM) and Neurotoxocariasis [8][9]. These drugs “quiet” the immune system to prevent permanent damage to delicate tissues like the eyes or brain [10][11].

3. Specialized Treatment for the Eye (OLM)

Because the eye is so fragile, Ocular Larva Migrans often requires more than just pills. Treatment goals focus on saving vision and stopping inflammation [12].

  • Injections and Implants: Doctors may use intravitreal injections (medication injected directly into the eye). This can include steroids or anti-VEGF drugs to stop abnormal blood vessel growth caused by the parasite [13][14].
  • Laser Treatment: If a doctor can actually see the larva during an eye exam, they may use a medical laser (photocoagulation) to neutralize it directly [15].
  • Surgery (Vitrectomy): If the infection has caused scarring or “tugging” on the retina (vitreoretinal traction), surgery may be needed to clear out debris and prevent a retinal detachment [12][16].

4. Monitoring Your Child’s Recovery

Recovery involves taking medication for days to weeks, but monitoring can last for months or even years [17].

  • The “Flare”: Be aware that symptoms can sometimes briefly worsen or return after the first round of treatment as the body processes the dying larvae. While this “flare” is a normal part of the process, you should call your doctor if your child develops a high fever, severe pain, or any new vision changes so they can adjust the steroid dosage [18].
  • Imaging Changes: If your child had lesions in their liver or lungs, these often get smaller or disappear on follow-up CT or MRI scans after treatment [3][19].
  • Blood Markers: Your doctor will likely re-check your child’s eosinophil count and IgE levels. A drop in these numbers is a strong sign that the treatment is working and the infection is settling down [20][17].

Common questions in this guide

Why does my child need steroids along with albendazole for toxocariasis?
Corticosteroids are used to control the severe inflammation that happens when the parasite larvae die off. Quieting the immune system is crucial to preventing permanent damage to delicate tissues, especially if the infection is in the brain or eyes.
What are the common side effects of albendazole?
Albendazole is usually well-tolerated by children. The most common side effects are mild and can include stomach upset, nausea, or dizziness. Your doctor will likely monitor liver enzymes if the medication is needed for an extended time.
What treatments are available for ocular larva migrans (OLM)?
Treatment for OLM focuses on saving vision and stopping inflammation. Depending on the severity, doctors may use intravitreal injections of steroids or anti-VEGF drugs, laser treatment to neutralize visible larvae, or surgery like a vitrectomy.
How will we know if the toxocariasis treatment is working?
Doctors track recovery by monitoring your child's blood work, specifically looking for a drop in eosinophil counts and IgE levels. They may also use follow-up CT or MRI scans to ensure any lesions in the liver or lungs are shrinking.
Is it normal for symptoms to flare up after starting treatment?
It is common for symptoms to briefly worsen as the body processes the dying larvae and triggers an inflammatory response. However, you should contact your doctor immediately if your child develops a high fever, severe pain, or new vision changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Why is the combination of albendazole and steroids necessary for my child's specific type of toxocariasis?
  2. 2.What are the most common side effects we should watch for with the anti-parasitic medication?
  3. 3.If my child is taking steroids, what is the 'taper' schedule (the plan for slowly lowering the dose) to prevent the inflammation from returning?
  4. 4.For eye involvement, are there non-surgical options like laser treatment or eye injections that we should consider first?
  5. 5.If surgery (like a vitrectomy) is needed for my child's eye, what are the goals for their vision and the risks involved?
  6. 6.How will we know if the treatment is working? Will we use repeat blood tests or follow-up imaging (MRI/CT)?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Prevalence of Toxocariasis and Its Risk Factors in Patients with Eosinophilia in Korea.

    Song HB, Lee D, Jin Y, et al.

    The Korean journal of parasitology 2020; (58(4)):413-419 doi:10.3347/kjp.2020.58.4.413.

    PMID: 32871635
  2. 2

    Clinical Features and Prognostic Factors in Northern Chinese Patients with Peripheral Granuloma Type of Ocular Toxocariasis: A Retrospective Cohort Study.

    Wang H, Tao Y

    Ocular immunology and inflammation 2021; (29(7-8)):1259-1264 doi:10.1080/09273948.2020.1804592.

    PMID: 33185484
  3. 3

    Toxocariasis Suspected of Having Infiltrated Directly from the Liver to the Lung through the Diaphragm.

    Kakimoto M, Murata M, Mitsumoto-Kaseida F, et al.

    Internal medicine (Tokyo, Japan) 2019; (58(18)):2737-2741 doi:10.2169/internalmedicine.2716-19.

    PMID: 31178505
  4. 4

    Treatment of larva migrans syndrome with long-term administration of albendazole.

    Hombu A, Yoshida A, Kikuchi T, et al.

    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 2019; (52(1)):100-105 doi:10.1016/j.jmii.2017.07.002.

    PMID: 28754237
  5. 5

    A Retrospective Study of the Efficacy of Albendazole and Diethylcarbamazine for the Treatment of Human Toxocariasis.

    Magnaval JF, Fillaux J, Berry A

    Pathogens (Basel, Switzerland) 2022; (11(7)) doi:10.3390/pathogens11070813.

    PMID: 35890057
  6. 6

    Albendazole Induced Recurrent Acute Toxic Hepatitis: A Case Report.

    Bilgic Y, Yilmaz C, Cagin YF, et al.

    Acta gastro-enterologica Belgica 2017; (80(2)):309-311.

    PMID: 29560698
  7. 7

    Who Let the Dogs Out? Unmasking the Neglected: A Semi-Systematic Review on the Enduring Impact of Toxocariasis, a Prevalent Zoonotic Infection.

    Henke K, Ntovas S, Xourgia E, et al.

    International journal of environmental research and public health 2023; (20(21)) doi:10.3390/ijerph20216972.

    PMID: 37947530
  8. 8

    Human toxocariasis - A look at a neglected disease through an epidemiological 'prism'.

    Rostami A, Ma G, Wang T, et al.

    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2019; (74()):104002 doi:10.1016/j.meegid.2019.104002.

    PMID: 31412276
  9. 9

    Toxocariasis of the Nervous System.

    Meliou M, Mavridis IN, Pyrgelis ES, Agapiou E

    Acta parasitologica 2020; (65(2)):291-299 doi:10.2478/s11686-019-00166-1.

    PMID: 31960218
  10. 10

    Clinical Characteristics of Pediatric Patients with Ocular Toxocariasis in China.

    Liu Y, Zhang Q, Li J, et al.

    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 2016; (235(2)):97-105 doi:10.1159/000443215.

    PMID: 26760978
  11. 11

    Neurotoxocariasis.

    Nicoletti A

    Advances in parasitology 2020; (109()):219-231 doi:10.1016/bs.apar.2020.01.007.

    PMID: 32381199
  12. 12

    Unilateral Vision Loss in a Child Revealing Ocular Toxocariasis.

    El Korno O, Hilali Z, Tachfouti S, et al.

    Cureus 2025; (17(12)):e99150 doi:10.7759/cureus.99150.

    PMID: 41531620
  13. 13

    Intravitreal Dexamethasone Implant (Ozurdex) for Ocular Toxocariasis.

    Zhou Y, Zhen F, Wu J, et al.

    Journal of ophthalmology 2024; (2024()):6685092 doi:10.1155/2024/6685092.

    PMID: 39041005
  14. 14

    Intravitreal Administration of Ranibizumab and Bevacizumab for Choroidal Neovascularization Secondary to Ocular Toxocariasis: A Case Report.

    Yoon DY, Woo SJ

    Ocular immunology and inflammation 2018; (26(4)):639-641 doi:10.1080/09273948.2016.1239744.

    PMID: 27775459
  15. 15

    Clinical experience in treatment of diffuse unilateral subretinal neuroretinitis.

    Relhan N, Pathengay A, Raval V, et al.

    Clinical ophthalmology (Auckland, N.Z.) 2015; (9()):1799-805 doi:10.2147/OPTH.S86989.

    PMID: 26491239
  16. 16

    Ocular Toxocariasis: Long-Term Follow-Up and Prognosis of Patients following Vitrectomy.

    Zhang T, Guo D, Xu G, Jiang R

    Ocular immunology and inflammation 2020; (28(3)):517-523 doi:10.1080/09273948.2019.1597897.

    PMID: 31305199
  17. 17

    Hepatic visceral larva migrans, a resilient entity on imaging: Experience from a tertiary liver center.

    Laroia ST, Rastogi A, Bihari C, et al.

    Tropical parasitology 2016; (6(1)):56-68 doi:10.4103/2229-5070.175100.

    PMID: 26998435
  18. 18

    A Rare Cause of Hypereosinophilia: A Case Report.

    Merdin A, Ogur E, Çiçek Kolak Ç, Avcı Merdin F

    Turkiye parazitolojii dergisi 2016; (40(2)):114-6 doi:10.5152/tpd.2016.4211.

    PMID: 27594294
  19. 19

    Neglected parasitic infection: toxocariasis.

    Tomoda Y, Futami S, Sumida K, Tanaka K

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2018-224492.

    PMID: 29540354
  20. 20

    Clinical and Laboratory Findings among Patients with Toxocariasis in Medic Medical Center, Ho Chi Minh City, Vietnam in 2017-2019.

    Phuc LDV, Loi CB, Quang HH, et al.

    Iranian journal of parasitology 2021; (16(4)):538-547 doi:10.18502/ijpa.v16i4.7864.

    PMID: 35082881

This page provides educational information about toxocariasis treatments and does not constitute medical advice. Always consult your pediatrician, ophthalmologist, or infectious disease specialist regarding your child's specific care plan.

Get notified when new evidence is published on Toxocariasis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.